Schrödinger Balance Sheet Health

Financial Health criteria checks 6/6

Schrödinger has a total shareholder equity of $474.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $688.4M and $214.4M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$377.29m
EquityUS$473.98m
Total liabilitiesUS$214.39m
Total assetsUS$688.37m

Recent financial health updates

Recent updates

Schrodinger: More Drug Discovery Validation

Aug 06

Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation

Aug 05
Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation

We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Jun 12
We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Schrödinger: More Pharmaceutical Than Software

May 07

Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar

May 02
Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar

Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially

Mar 01
Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially

Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024

Mar 01

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Feb 28
Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%

Feb 01
The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%

Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable

Dec 18
Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Sep 28
Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?

Jul 01
Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?

Schrödinger: Q2 Earnings Supports Growth Narrative

Aug 26

Schrödinger appoints Dr. Geoffrey Porges as finance chief

Aug 18

Sizing Up Schrodinger

Jun 06

Schrödinger: Holding The Keys To Discovery

Mar 26

Schrodinger: A Long-Term Hold For Biotech Investors With Upside Potential Too

Mar 15

Schrödinger: Conviction Remains High, Q4 Report And Guidance Will Be Critical

Jan 06

After Its Stock Price Doubled Last Year, Why Schrödinger Is Slumping Now

Nov 24

We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow

Nov 12
We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 38% Undervalued

Oct 05
An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 38% Undervalued

Schrodinger: An Investment In Drug Discovery In Addition To Software Sales

Sep 20

Financial Position Analysis

Short Term Liabilities: SDGR's short term assets ($449.2M) exceed its short term liabilities ($99.8M).

Long Term Liabilities: SDGR's short term assets ($449.2M) exceed its long term liabilities ($114.6M).


Debt to Equity History and Analysis

Debt Level: SDGR is debt free.

Reducing Debt: SDGR has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SDGR has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SDGR has sufficient cash runway for 3 years if free cash flow continues to reduce at historical rates of 40.9% each year.


Discover healthy companies